Related Experiment Videos
Exploiting T cell receptor genes for cancer immunotherapy
1Imperial College London, Department of Immunology, Hammersmith Hospital Campus, London, UK.
Clinical and Experimental Immunology
|January 19, 2005
Summary
T-cell receptor (TCR) gene therapy offers a novel approach to cancer treatment. This method engineers a patient's T cells to target cancer antigens, enabling effective immunotherapy even in immunocompromised individuals.
Area of Science:
- Immunology
- Oncology
- Gene Therapy
Background:
- Adoptive antigen-specific immunotherapy is promising for cancer treatment.
- Conventional adoptive T cell therapy faces limitations due to difficulties in isolating and expanding antigen-specific T cells.
- Tumor-associated antigens often elicit weak T cell responses in patients.
Purpose of the Study:
- To explore the potential of T-cell receptor (TCR) gene transfer as a method for unconventional antigen-specific immunotherapy.
- To overcome the limitations of conventional adoptive T cell therapy.
- To develop a generic treatment option for cancer using autologous lymphocytes.
Main Methods:
- Isolation of TCR genes from antigen-specific T cells.
- Retroviral gene transfer of TCR genes into patient T cells.
- In vitro expansion and functional assessment of gene-modified T cells.
- In vivo efficacy studies in murine cancer models.
Main Results:
- Retroviral TCR gene transfer successfully generated antigen-specific T cell populations after a single polyclonal stimulation.
- TCR gene-modified lymphocytes demonstrated functional competence in vitro.
- Therapeutic efficacy was observed in murine models.
- Stable TCR gene expression and development of memory T cells were noted.
- Introduction of TCR genes into both CD8(+) and CD4(+) T cells allowed for the generation of both killer and helper T lymphocytes with the same specificity.
Conclusions:
- TCR gene therapy provides a viable strategy for developing antigen-specific immunotherapy.
- This approach can utilize autologous lymphocytes as a generic treatment option for cancer.
- TCR gene therapy overcomes the challenges associated with isolating and expanding antigen-specific T cells, making immunotherapy more accessible.